CMS Considers Expanded HIV-Screening Coverage
This article was originally published in The Gray Sheet
The Medicare agency has been asked to update its HIV-screening coverage policy to align with recent recommendations that all adults and adolescents be screened regardless of perceived risk.
You may also be interested in...
Spectrum buys majority stake in Shaser Bioscience. Sorin snaps up Neurotech. Nihon Kohden acquires Defibtech. More news briefs.
The nine drug manufacturers with products selected for Medicare drug price negotiations have agreed to participate in the program. Seven of them now have pending suits challenging the Inflation Reduction Act program with Novo’s recent complaint, which objects to the aggregation of its insulin products.
Drug manufacturers will have to participate in the Medicare drug price negotiation process for the foreseeable future. Judge Newman's finding that participation in Medicare is voluntary could defeat constitutional challenges to the program and have an impact on other cases.